Cannell Capital LLC Eton Pharmaceuticals, Inc. Transaction History
Cannell Capital LLC
- $283 Million
- Q1 2025
A detailed history of Cannell Capital LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Cannell Capital LLC holds 691,367 shares of ETON stock, worth $12 Million. This represents 3.17% of its overall portfolio holdings.
Number of Shares
691,367
Previous 381,323
81.31%
Holding current value
$12 Million
Previous $5.01 Million
78.96%
% of portfolio
3.17%
Previous 1.09%
Shares
2 transactions
Others Institutions Holding ETON
# of Institutions
95Shares Held
15.2MCall Options Held
61.2KPut Options Held
33.1K-
Opaleye Management Inc. Boston, MA2.85MShares$49.4 Million10.18% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.94MShares$33.6 Million1.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$22.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$20.4 Million0.69% of portfolio
-
Geode Capital Management, LLC Boston, MA593KShares$10.3 Million0.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $438M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...